Research to narrow down patients with liver cirrhosis hidden in health checkup examinees
Not Applicable
- Conditions
- iver cirrhosis
- Registration Number
- JPRN-UMIN000041609
- Lead Sponsor
- Musashino Red Cross Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with HCV, HBV, AIH and PBC
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnostic accuracy of liver cirrhosis
- Secondary Outcome Measures
Name Time Method survival, liver carcinogenesis, cirrhosis
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What non-invasive biomarkers are used to detect occult liver cirrhosis in asymptomatic health checkup populations?
How does the study's approach compare to FibroScan or APRI score in identifying subclinical liver fibrosis/cirrhosis?
What molecular pathways (e.g., TGF-β, collagen markers) are being evaluated for early cirrhosis detection in this observational trial?
Are there specific viral hepatitis subtypes (HBV, HCV) or metabolic factors (NASH) prioritized in patient selection criteria?
What are the long-term prognostic implications of early cirrhosis identification through Musashino Red Cross Hospital's observational cohort?